Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19). Issue 2 (August 2021) - Pallotto, Carlo
Highlights: Remdesivir is the only antiviral approved for COVID-19. Remdesivir treatment was associated with transient bradycardia. Bradycardia did not cause any severe clinical manifestation.